Comparison of Mammography Findings of Triple Negative Breast Cancer with Non Triple Negative Breast Cancer Subtypes: A Retrospective Observational Study
Year: 2025
Type: article
Study design: Observational Study
Abstract: Introduction: Different molecular subtypes of breast cancer demonstrate variations in their clinical course, treatment response, and prognosis, which are defined by the expression of biological markers Estrogen Receptor (ER), Progesterone Receptor (PR) and Human Epidermal Growth Factor Receptor 2 (HER2). Aim: To analyse the spectrum of mammography findings in different Immunohistochemical (IHC) subtypes of breast cancer and to compare the findings of Triple negative Breast Cancer (TNBC) with other non TNBC subtypes. Materials and Methods: A retrospective observational study was conducted at the Department of Radiodiagnosis and Interventional Radiology, Dr. DY Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India, from December 2023 to March 2024. A total of 65 histopathology-proven breast cancer patients with a known IHC profile were included. Mammography findings were analysed in four major IHC subtypes, namely Luminal A (HR+, HER2-), Luminal B (HR+, HER2+), HER2-enriched (HR-, HER2+), and triple negative (HR-, HER2-). Imaging findings of TNBC were also compared with those of other non TNBC subtypes. The association between different variables was compared using the Chi-square test. For all the tests, a p-value of <0.05 (two-tailed) was considered statistically significant. Results: The age of patients ranged from 30 to 83 years (Mean=53.7 years). The most common finding was a mass, which was present in 56 (86%) cases. Asymmetry was the least common finding, observed in 8 (12%) of cases. A total of 24 (36.9%) cases were classified as Luminal A, followed by 22 (33.8%) cases classified as TNBC. A total of 18.2% of TNBC cases demonstrated suspicious micro-calcifications, compared to 46.5% of non TNBC cases (p-value 0.031). The margins of the mass were circumscribed in 8 (40%) of TNBC cases, in comparison to other molecular subtypes (p-value 0.001). Conclusion: The characterisation of mammography findings in various IHC subtypes aids in diagnosis and management planning.
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $275
OpenAlex ID: W4409707571
